CHRONIC RHINOSINUSITIS: PATHOPHYSIOLOGY, DIAGNOSIS, AND EVIDENCE-BASED TREATMENT
Keywords:
chronic rhinosinusitis, children, topical antibacterial therapy, fusafungine, EPOS, nasal polyps.Abstract
The article discusses current concepts of chronic inflammation of the paranasal
sinuses in children (chronic rhinosinusitis, CRS) based on the European Position Paper
on Rhinosinusitis and Nasal Polyps 2012 (EPOS 2012). The structure of bacterial
pathogens, trigger factors of CRS, and modern treatment recommendations are
presented. Special attention is given to the use of topical antibacterial therapy,
particularly fusafungine (Bioparox), in children over 12 years of age with CRS.
References
1.
Lopatin A.S., Gamov V.P. Acute and Chronic Rhinosinusitis: Etiology,
Pathogenesis, Clinical Features, Diagnosis and Treatment Principles. Moscow:
Medical Information Agency; 2011: 8–59.
2.
Fokkens W., Lund V., Mullol J., et al. European Position Paper on
Rhinosinusitis and Nasal Polyps 2012 (EPOS). Rhinology. 2012;50(Suppl 23):1–299.
3.
Ryazantsev S.V. Comparison of Russian Treatment Standards for Acute
Sinusitis with EPOS International Guidelines. Consilium Medicum. 2008;10:87–90.
4.
Karpova E.P., Martynova I.V. Treatment of Rhinosinusitis in Children with
Cystic Fibrosis. Russian Otorhinolaryngology. 2011;3(52):90–94.
5.
Larsen P.L., Tos M. Origin of Nasal Polyps. The Laryngoscope.
1991;101(3):305–312.
